Serge Gauthier
Serge Gauthier
Verified email at
Cited by
Cited by
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium
IG McKeith, DW Dickson, J Lowe, M Emre, JT O'brien, H Feldman, ...
Neurology 65 (12), 1863-1872, 2005
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
B Dubois, HH Feldman, C Jacova, ST DeKosky, P Barberger-Gateau, ...
The Lancet Neurology 6 (8), 734-746, 2007
Mild cognitive impairment
S Gauthier, B Reisberg, M Zaudig, RC Petersen, K Ritchie, K Broich, ...
The lancet 367 (9518), 1262-1270, 2006
Clinical diagnostic criteria for dementia associated with Parkinson's disease
M Emre, D Aarsland, R Brown, DJ Burn, C Duyckaerts, Y Mizuno, GA Broe, ...
Movement disorders: official journal of the Movement Disorder Society 22 (12 …, 2007
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
B Dubois, HH Feldman, C Jacova, H Hampel, JL Molinuevo, K Blennow, ...
The Lancet Neurology 13 (6), 614-629, 2014
Revising the definition of Alzheimer's disease: a new lexicon
B Dubois, HH Feldman, C Jacova, JL Cummings, ST DeKosky, ...
The Lancet Neurology 9 (11), 1118-1127, 2010
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial
DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ...
The Lancet 368 (9541), 1096-1105, 2006
Vascular cognitive impairment
J T O'Brien, T Erkinjuntti, B Reisberg, G Roman, T Sawada, L Pantoni, ...
The Lancet Neurology 2 (2), 89-98, 2003
Levodopa and the progression of Parkinson's disease
Parkinson Study Group
New England Journal of Medicine 351 (24), 2498-2508, 2004
Apolipoprotein E polymorphism and Alzheimer's disease
J Poirier, P Bertrand, S Kogan, S Gauthier, J Davignon, D Bouthillier
The Lancet 342 (8873), 697-699, 1993
Prevalence and severity of cognitive impairment with and without dementia in an elderly population
JE Graham, K Rockwood, BL Beattie, R Eastwood, S Gauthier, H Tuokko, ...
The Lancet 349 (9068), 1793-1796, 1997
Variable expression of Parkinson's disease: A base‐line analysis of the DAT ATOP cohort
J Jankovic, M McDermott, J Carter, S Gauthier, C Goetz, L Golbe, S Huber, ...
Neurology 40 (10), 1529-1529, 1990
Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trialCommentary: Another piece of the Alzheimer's jigsaw
M Rösler, T Bayer, R Anand, A Cicin-Sain, S Gauthier, Y Agid, ...
Bmj 318 (7184), 633-640, 1999
Defeating Alzheimer's disease and other dementias: a priority for European science and society
B Winblad, P Amouyel, S Andrieu, C Ballard, C Brayne, H Brodaty, ...
The Lancet Neurology 15 (5), 455-532, 2016
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials
M Grundman, RC Petersen, SH Ferris, RG Thomas, PS Aisen, DA Bennett, ...
Archives of neurology 61 (1), 59-66, 2004
Mild cognitive impairment: a concept in evolution
RC Petersen, B Caracciolo, C Brayne, S Gauthier, V Jelic, L Fratiglioni
Journal of internal medicine 275 (3), 214-228, 2014
Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial
T Erkinjuntti, A Kurz, S Gauthier, R Bullock, S Lilienfeld, CRV Damaraju
The Lancet 359 (9314), 1283-1290, 2002
Development of a functional measure for persons with Alzheimer’s disease: the disability assessment for dementia
I Gélinas, L Gauthier, M McIntyre, S Gauthier
American Journal of Occupational Therapy 53 (5), 471-481, 1999
Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force
B Dubois, D Burn, C Goetz, D Aarsland, RG Brown, GA Broe, D Dickson, ...
Movement disorders 22 (16), 2314-2324, 2007
Dementia with Lewy bodies
I McKeith
Handbook of clinical Neurology 84, 531-548, 2007
The system can't perform the operation now. Try again later.
Articles 1–20